IRIS
MUSOLINO, Caterina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 12.466
NA - Nord America 11.846
AS - Asia 6.373
SA - Sud America 2.418
Continente sconosciuto - Info sul continente non disponibili 439
AF - Africa 219
OC - Oceania 16
Totale 33.777
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.531
RU - Federazione Russa 6.250
SG - Singapore 2.797
BR - Brasile 2.091
CN - Cina 1.706
IE - Irlanda 1.519
SE - Svezia 1.273
IT - Italia 887
HK - Hong Kong 710
DE - Germania 532
FR - Francia 422
UA - Ucraina 386
VN - Vietnam 364
GB - Regno Unito 280
FI - Finlandia 279
PL - Polonia 241
IN - India 157
CA - Canada 133
AR - Argentina 115
BD - Bangladesh 113
MX - Messico 87
TR - Turchia 72
ZA - Sudafrica 66
ID - Indonesia 63
HU - Ungheria 61
AT - Austria 60
BE - Belgio 59
EC - Ecuador 59
NL - Olanda 56
IQ - Iraq 52
ES - Italia 48
CO - Colombia 46
JP - Giappone 45
MA - Marocco 37
PK - Pakistan 36
UZ - Uzbekistan 34
KE - Kenya 30
VE - Venezuela 28
TN - Tunisia 25
EG - Egitto 22
PY - Paraguay 21
HN - Honduras 19
IR - Iran 19
PH - Filippine 19
CL - Cile 17
CZ - Repubblica Ceca 17
JM - Giamaica 17
AE - Emirati Arabi Uniti 16
BO - Bolivia 16
CR - Costa Rica 15
SA - Arabia Saudita 15
LT - Lituania 14
DO - Repubblica Dominicana 13
JO - Giordania 13
AZ - Azerbaigian 12
IL - Israele 12
UY - Uruguay 12
KR - Corea 11
GR - Grecia 10
MY - Malesia 10
NI - Nicaragua 10
NP - Nepal 10
PE - Perù 10
AU - Australia 9
KG - Kirghizistan 9
OM - Oman 9
PS - Palestinian Territory 9
RO - Romania 9
BG - Bulgaria 8
LB - Libano 8
NO - Norvegia 8
KZ - Kazakistan 7
SN - Senegal 7
AL - Albania 6
AO - Angola 6
CH - Svizzera 6
DK - Danimarca 6
LV - Lettonia 6
NZ - Nuova Zelanda 6
SY - Repubblica araba siriana 6
TH - Thailandia 6
TW - Taiwan 6
CI - Costa d'Avorio 5
GE - Georgia 5
SK - Slovacchia (Repubblica Slovacca) 5
TT - Trinidad e Tobago 5
DZ - Algeria 4
ET - Etiopia 4
EU - Europa 4
PA - Panama 4
RS - Serbia 4
AM - Armenia 3
BH - Bahrain 3
KH - Cambogia 3
KW - Kuwait 3
LY - Libia 3
MD - Moldavia 3
PR - Porto Rico 3
PT - Portogallo 3
XK - ???statistics.table.value.countryCode.XK??? 3
Totale 33.304
Salva come PNG Salva come JPEG
Città #
Moscow 1.902
Ashburn 1.829
Dublin 1.518
Singapore 1.503
Chandler 1.272
Dallas 1.043
Jacksonville 802
Nyköping 727
Hong Kong 710
Beijing 591
San Jose 524
Council Bluffs 390
Messina 353
The Dalles 345
Princeton 279
Dearborn 270
Medford 258
Lauterbourg 249
Los Angeles 246
Warsaw 219
Des Moines 215
Cambridge 209
Ann Arbor 185
São Paulo 181
New York 173
Boardman 139
Munich 126
Buffalo 116
Ho Chi Minh City 106
Santa Clara 89
Tianjin 88
Hanoi 82
Woodbridge 77
Redondo Beach 74
Frankfurt am Main 71
Wilmington 66
Rio de Janeiro 65
Belo Horizonte 63
Budapest 59
Brussels 57
Guangzhou 57
San Mateo 56
Jinan 51
Vienna 50
Brasília 43
Johannesburg 43
Milan 43
Columbus 42
Houston 42
Orem 42
Turku 42
Montreal 41
Nanjing 41
Shenyang 41
Tokyo 41
Chennai 39
Seattle 39
Atlanta 38
Hebei 36
Lancaster 36
Brooklyn 35
Porto Alegre 34
Helsinki 33
Pune 33
Shanghai 33
Bremen 32
London 32
Nuremberg 31
Rome 31
Chicago 30
Curitiba 29
Hangzhou 28
Jakarta 28
Tashkent 28
Denver 27
Dong Ket 27
Quito 27
San Francisco 27
Stockholm 27
Zhengzhou 27
Amsterdam 26
Nairobi 26
Secaucus 25
Boston 23
Poplar 23
Strasbourg 23
Toronto 23
Guarulhos 21
North Bergen 21
Ningbo 20
Palermo 20
Ribeirão Preto 20
Newark 19
Campinas 18
Düsseldorf 18
Haikou 18
Manchester 18
Recife 18
Salvador 18
Shenzhen 17
Totale 19.148
Salva come PNG Salva come JPEG
Nome #
Altered Microrna Expression Profile in the peripheral Lymphomonocytes of Multiple Myeloma Patients with Bisphosphonate-Induced Osteonecrosis of the Jaw 300
EVALUATION OF THROMBIN GENERATION POTENTIAL IN POLYCYTHEMIA VERA PATIENTS ENROLLED IN THE CYTO–PV ITALIAN CLINICAL TRIAL 293
Diagnostic utility of Sudoscan for detecting Bortezomib-induced painful neuropathy 257
A multivariate analysis of Multiple Myeloma subtype plasma cells 251
A micro-Raman spectroscopic investigation of leukemic U-937 cells in aged cultures 245
SIRT1 and SIRT2 Expression correlates with advanced disease and bone lesions in Multiple Myeloma 244
Altered microRNA expression profile in the peripheral lymphoid compartment of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw 237
Bisphosphonates induce apoptosis of circulating endothelial cells in multiple myeloma patients and in subjects with bisphosphonate-induced osteonecrosis of the jaws 216
Effect of therapeutic plasma exchange on plasma levels of oxidative biomarkers in a patient with thrombotic thrombocytopenic purpura 211
Challenge test to bisphosphonates in patients with hypersensitivity reactions to drugs. 207
E rosette formation in B cell chronic lymphocytic leukemia. 205
Corneal Structural Changes in Nonneoplastic and Neoplastic Monoclonal Gammopathies 204
MDR-1 gene polymorphisms G2677T and C3435T in a case of Hodgkin's variant of Richter's syndrome 202
Adoptive immunotherapy for hematological malignancies: Current status and new insights in chimeric antigen receptor T cells 201
Comportamento di alcuni indici della fibrinolisi in dislipidemici in corso di trattamento con sinfibrato" 198
Absence of the V617F JAK2 Mutation in the Lymphoid Compartment in a Patient with Essential Thrombocythemia and B-Chronic Lymphocytic Leukemia and in Two Relatives with Lymphoproliferative Disorders 198
Circulating microRNAs: New biomarkers in diagnosis, prognosis and treatment of cancer (Review). 197
Curcumin ameliorates the in vitro efficacy of carfilzomib in human multiple myeloma U266 cells targeting p53 and NF-kB pathways 197
Concentration of circulating endothelial progenitor cells (EPC) in normal pregnancy and in pregnant women with diabetes and hypertension 195
Disappearance of Acquired Hemophilia A after Complete Remission in a Multiple Myeloma Patient. 195
Evaluation of the AGE/sRAGE Axis in Patients with Multiple Myeloma 193
A rare spinal localization of gray zone lymphoma without mediastinal involvement: A case report and review of literature 193
Aggregazione piastrinica in dislipidemici in corso di trattamento con simfibrato 192
Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical Studies 189
Bisphosphonate-associated osteonecrosis of the jaw in patients with multiple myeloma and breast cancer. 188
ASSETTO EMATOLOGICO DI UN GRUPPO DI SOGGETTIAFFETTI DA MORBO DI COOLEY:STUDIO DEL COMPORTAMENTO DELL'ERITROPOIETINA PLASMATICA 188
Novel therapeutic strategies in multiple myeloma: role of the heat shock protein inhibitors 186
Cerebral venous sinus thrombosis (CVST) associated with SARS-CoV-2 vaccines: clues for an immunopathogenesis common to CVST observed in COVID-19 186
Efficacia della chemioterapia convenzionale ad alte dosi in un caso di mieloma multiplo IgM primitivamente doppio-refrattario ai nuovi farmaci 185
Absence of the V617F JAK2 mutation in the lymphoid compartment in a patient with essential thrombocythemia and B-chronic lymphocytic leukemia and n two relatives with lymphoproliferative disorders 184
Curcumin Ameliorates the In Vitro Efficacy of Carfilzomib in Human Multiple Myeloma U266 Cells Targeting p53 and NF-κB Pathways. 182
Anxiety, Depression, Distress, and Resilience in Patients with Haematological Malignancies. The Effect of Nine Weeks of Psychological Support on Psychological Status and Stress Biological Markers 182
Raman spectroscopy differentiates between sensitive and resistant multiple myeloma cell lines 180
Risk stratification and early cardiotoxicity identification: organizational advantages and clinical impact of intrahospital cardiotoxicity network 179
Circulating levels of intercellular adhesion molecule-1 (ICAM-1) and soluble interleukin 2 receptors (IL-2R) in patients with B cell chronic lymphocytic leukaemia. 178
Avascular Necrosis of Bone in Leukemia and Osteonecrosis of Jaw by Bisphosphonates 178
L'ipersplenismo: attualità e prospettive future 177
Cutaneous adverse reactions to lenalidomide. 176
ABERRANT EXPRESSION OF CANCER TESTIS ANTIGENS IN HEMATOLOGIC MALIGNANCIES 175
Vaccination of multiple myeloma: Current strategies and future prospects 175
Changes in serum interleukin-8 and sRAGE levels in multiple myeloma patients 174
Antiresorptive Agents and Anti-Angiogenesis Drugs in the Development of Osteonecrosis of the Jaw. 173
Angiogenesis in patients with biphosphonate-associated osteonecrosis of the jaw 170
Increased levels of the soluble adhesion molecule E-selectin in patients with chronic myeloproliferative disorders and thromboembolic complications 170
Beta 2 microglobulina ed emopatie maligne 170
Assenza della mutazione JAK2 V617F nel compartimento linfoide di un paziente affetto da trombocitemia essenziale e leucemia linfatica cronica a cellule B ed in due parenti affetti da disordini linfoproliferativi 169
Telomerase and telomere biology in hematological diseases: A new therapeutic target 169
A phase 2 study of three low-dose intensity subcutaneous bortezomib regimens in elderly frail patients with untreated multiple myeloma 165
Myeloma cells induce the accumulation of activated CD94low NK cells by cell-to-cell contacts involving CD56 molecules 164
Circulating levels of intercellular adhesion Molecule-1 (ICAM-1) and soluble Interleukin 2 receptors(IL-2R) in patients with B cell Chronic Lynphocityc Leukemia 161
[Calcium and endocrine pancreas secretion. II. Effects of an infusion of calcium on insulin and glucagon secretion induced by intravenous administration of glucose]. 161
Circulating endothelial progenitor cells and angiogenic serum factors in patients with chronic myeloproliferative diseases 160
A progression-risk score to predict treatment-free survival for early stage chronic lymphocytic leukemia patients 160
Cancer and sars-cov-2 infection: Diagnostic and therapeutic challenges 160
Global cardiovascular assessment in patients with PH+ chronic myeloid leukaemia treated with TKI: long-term follow-up 160
Low-energy laser irradiation promotes cellular damage in glucocorticoid-resistant multiple myeloma cells. 159
Serum levels of interleukin-16 in lymphoid malignancies. 159
Amyloid myopathy presenting with rhabdomyolysis: Evidence of complement activation 158
ARA-C a basse dosi nelle sindrome mielodisplastiche in differenti stati evolutivi 158
Phage-AgNPs complex as SERS probe for U937 cell identification 158
Successful management of a pregnant patient with chronic myeloid leukemia receiving standard dose imatinib 158
Carbonyl groups serum levels are associated with CD38 expression in patients with B chronic lymphocytic leucemia. 156
Risk of occult hepatitis B virus infection reactivation in patients with solid tumours undergoing chemotherapy 156
Vaccination strategies in lymphoproliferative disorders: Failures and successes 155
A population-based study of chronic myeloid leukemia patients treated with imatinib in first line 155
The cancer stem cell hypothesis: a guide to potential molecular targets. 154
Hepatitis B Virus Causes Epigenetic Induction of Interleukin-8Production which in Turn Inhibits Interferon-alfa Antiviral Activity 154
MiRNome expression is deregulated in the peripheral lymphoid compartment of multiple myeloma 154
Standardisation of minimal residual disease in multiple myeloma 154
Anticancer activity of rosmarinus officinalis L.: Mechanisms of action and therapeutic potentials 154
MDR-1 polymorphisms (G2677T and C3435T) in B-chronic lymphocytic leukemia: an impact on susceptibility and prognosis. 153
Association of osteonecrosis of the jaws and POEMS syndrome in a patient assuming rituximab. 152
Increase in serum protein carbonyl groups is associated with more advanced stage of disease in multiple myeloma patients. 151
FITC-labelled clone from phage display for direct detection of leukemia cells in blood 151
Allergy and risk of hematologic malignancies: Associations and mechanisms. 150
Immunohistochemical evaluation of sarcoglycans and integrins in gingival epithelium of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw. 149
Antiproliferative effects of st. John’s wort, its derivatives, and other hypericum species in hematologic malignancies 149
Possible role of Interleuki-31/33 Axis in Imatinib Mesylate-Associated Skin Toxicity 147
Decreased plasma levels of IL-33 could contribute to the altered function of Th2 Iymphocytes in patients with poIycythemia vera and essential thrombocythemia. 145
Changes in advanced oxidation protein products, advanced glycation end products, and s-nitrosylated proteins, in patients affected by polycythemia vera and essential thrombocythemia 145
How gene polymorphisms can influence clinical response and toxicity following R-CHOP therapy in patients with diffuse large B cell lymphoma 145
Patients with bisphosphonate-associated osteonecrosis of the jaw have unmodified levels of soluble vascular endothelial growth factor receptor 1. 144
Immunoproteasome-selective and non-selective inhibitors: A promising approach for the treatment of multiple myeloma. 144
Antitumorigenic action of nelfinavir: Effects on multiple myeloma and hematologic malignancies (Review) 142
Chromosome 1 abnormalities in elderly patients with newly diagnosed multiple myeloma treated with novel therapies. 141
Cardiac involvement in patients with hematologic malignancies. 139
Effetti di uno stress fisico sulla funzione pistrinica e su alcuni parametri emocoagulativi e della fibrinolisi 139
The metabolomic signature of hematologic malignancies 139
Role of the microbiota in hematologic malignancies. 139
DIFFERENT DAILY BLOOD GLUCOSE CONTROL AND FREE INSULIN LEVELS DURING TREATMENT WITH MIXTURES OF SOLUBLE AND LENTE OR SOLUBLE AND NPH SEMISYNTHETIC HUMAN INSULINS. 138
Efficacy of biosimilar granulocyte colony-stimulating factor versus originator granulocyte colony-stimulating factor in peripheral blood stem cell mobilization in de novo multiple myeloma patients 138
Coagulopathy and thromboembolic events in patients with SARS-CoV-2 infection: pathogenesis and management strategies 138
Immunohistochemical evaluation of sarcoglycans and integrin in gingival epithelium of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw 136
A phase II study of Givinostat in combination with hydroxycarbamide in patients with polycythaemia vera unresponsive to hydroxycarbamide monotherapy. 136
Oxidative stress in oncohematologic diseases: an update. 136
Patients with bisphosphonates-associated osteonecrosis of the jaw have reduced circulating endothelial cells 136
Castleman–Kojima disease (TAFRO syndrome) in a Caucasian patient: A rare case report and review of the literature 135
Monocytes and lymphocytes as active participants in the pathogenesis of experimental shock 134
The adipose organ and multiple myeloma: Impact of adipokines on tumor growth and potential sites for therapeutic intervention 133
Raman spectroscopy is able to discriminate between CD138-/CD138+ plasmacells of multiple myeloma patients. 129
Totale 17.200
Salva come PNG Salva come JPEG
Categoria #
all - tutte 118.261
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 118.261
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.621 0 118 24 73 54 23 101 65 54 225 222 662
2022/20234.587 409 392 215 409 312 466 53 231 1.862 27 146 65
2023/20241.087 100 197 70 85 98 247 26 71 11 27 16 139
2024/20255.537 136 85 99 337 304 143 91 1.253 1.479 316 463 831
2025/202615.522 702 1.031 1.190 1.087 1.338 3.266 1.892 1.842 1.867 609 252 446
2026/2027894 403 491 0 0 0 0 0 0 0 0 0 0
Totale 33.777